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INTRODUCTION
Due to its many advantages over other techniques, the loop
electrosurgical excisional procedure (LEEP) is the most pop-
ular method for treating and diagnosing cervical dysplasia in
the United States (1). The LEEP is technically easy, requires
short operation time, has a low complication rate, and can be
done in the office setting. However, LEEP also has some dis-
advantages. For example, deep endocervical lesions are hard
to remove with a single pass of a loop. Therefore, for deep
endocervical lesions, some authors reported use of a second
pass with a smaller-diameter loop (2-5). The second-pass tech-
nique is also known as “apical excision”, “top hat shaped exci-
sion”, and “LEEP-cone” (1).
Because more endocervical tissues are removed, the sec-
ond pass technique has been believed to reduce the incom-
plete resection than the conventional single-pass technique.
In addition, the second-pass technique has been shown to
be equivalent to a cold-knife conization if performed prop-
erly (6). However, to our knowledge, there have been few
studies that compared the second-pass technique with the
single-pass technique.
We hypothesized that, compared to the single-pass tech-
nique, the second-pass technique could reduce the incom-
plete resection and treatment failure of LEEP. The aim of this
study was to compare the incomplete resection rate and treat-
ment outcome of second-pass technique with those of single-
pass technique.
MATERIALS AND METHODS
Patients and LEEP techniques
Between January 1997 and June 2002, 683 women were
diagnosed as squamous dysplasia via LEEP in our institution.
The LEEP was performed with a variable sized loop electrode.
LEEP technique was chosen considering the location of lesion,
the size and shape of cervix, the plan for childbearing, and the
operators’ preferences. When the second-pass technique was
used, specimens from the first- and second-passes were labeled
separately. The orientation of specimens was indicated using
a stitch on anterior, exocervical margin of a specimen.
Clinicopathologic characteristics
Age, parity, LEEP technique, grade of lesion, glandular ex-
tension, and margin status were obtained by reviewing med-
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Value of Second Pass in Loop Electrosurgical Excisional Procedure
The aim of this study was to compare the rate of incomplete resection and treatment
outcome of the second-pass technique with those of single-pass technique in loop
electrosurgical excisional procedure (LEEP). From 1997 to 2002, 683 women were
diagnosed as squamous dysplasia via LEEP in our institution. Age, parity, LEEP
technique, grade of lesion, glandular extension, margin status, residual tumor and
recurrence were obtained by reviewing medical records. Positive margin was defined
as mild dysplasia or higher grade lesions at resection margin of the LEEP speci-
men. In women who underwent hysterectomy, residual tumor was defined as mild
dysplasia or higher grade lesions in hysterectomy specimen. In women who did not
underwent hysterectomy, Pap smear more than atypical squamous cells of unde-
termined significance or biopsy result more than mild dysplasia within two years
after LEEP were regarded as cytologic or histologic recurrences, respectively. Treat-
ment failure of LEEP was defined as residual tumor or histologic recurrence. The
second-pass technique significantly reduced the endocervical margin positivity (odds
ratio [OR], 0.36; 95% confidence interval [CI], 0.21-0.63). However, the second-pass
technique did not reduce the treatment failure (OR, 0.62; 95% CI, 0.29-1.32). In
conclusion, the second-pass technique markedly reduced the endocervical margin
positivity, but did not reduce the treatment failure rate of LEEP.
Key Words : Second-Pass Technique; Cervical Intraepithelial Neoplasia; Loop Electrosurgical Excisional
Procedure; Endocervical Margin Involvement; Conization
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ical records. In women who underwent hysterectomy with-
in three months after LEEP, the presence of residual tumor
in hysterectomy specimen was investigated. In women who
did not undergo immediate hysterectomy, Pap smear results
within two years after LEEP were obtained. ‘Adequate fol-
low-up’ was defined as three or more Pap smears within two
years after LEEP. ‘Inadequate follow-up’ was defined as Pap
smears less than three times within two years. Women with
abnormal Pap smear or biopsies within two years were regard-
ed as ‘adequate follow-up’ even if she received Pap smear less
than three times. Pap smear more than atypical squamous
cells of undetermined significance (ASCUS) was regarded as
cytologic recurrence and biopsy result more than mild dys-
plasia was defined as histologic recurrence. Treatment fail-
ure of LEEP was defined as residual tumor in hysterectomy
specimen or histologic recurrence in women who were under
adequate follow-up.
All specimens were evaluated at the department of pathol-
ogy. Margin status was reported as positive if mild dysplasia
or higher grade lesions were present at resection margin of
LEEP specimen. In women who underwent hysterectomy, the
residual tumor was defined as the presence of mild dysplasia
or higher grade lesions.
Statistical analysis
Results were considered statistically significant if a p value
of ≤0.05 was obtained. Chi-square test and linear by linear
association method were utilized to test for univariate rela-
tionships between clinicopathologic characteristics and LEEP
techniques. Univariate and multivariate logistic regression
analysis were used to evaluate the associations of clinicopatho-
logic risk factors with endocervical margin positivity on LEEP
specimen or treatment failure. Chi-square test and Fisher’s
exact test were used to evaluate the univariate associations of
LEEP technique with residual tumor or recurrences. Analy-
sis of the data was performed using SPSS for Windows Ver-
sion 12 (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Clinicopathologic characteristics
The single-pass technique was used in 550 women (80.5%)
and the second-pass technique was used in 133 women (19.5
%). Age distribution of single-pass group was not different
from that of second-pass group (p=0.942). Records on parity
were available in only 463 women (67.8%). Parity of single
pass group was not different from that of second-pass group
(p=0.181). The portions of mild, moderate, severe dysplasia,
and carcinoma in situ (CIS) were similar between the sin-
gle-pass and second-pass groups (p=0.911). Glandular exten-
sion was present in about half of women from both the single-
pass and second-pass groups (p=0.866). Endocervical margin
positivity was 27.6% in single-pass group and 12.8% in sec-
ond-pass group (p=0.000). In the single-pass group, over half
of women underwent hysterectomy within three months after
LEEP. However, in the second-pass group, only one third of
women underwent hysterectomy (p=0.000) (Table 1).
Effect of second-pass technique on endocervical margin
positivity
Compared to single-pass technique, the second-pass tech-
nique significantly reduced the endocervical margin positivi-
ty (odds ratio [OR], 0.36; 95% confidence interval [CI], 0.21-
0.63). However, higher grade lesion and glandular extension
increased endocervical margin positivities. Moderate, severe
dysplasia, and CIS had about four, eight, and seventeen times
more endocervical margin positivities than mild dysplasia,
respectively. Glandular extension increased endocervical mar-
gin positivity nearly twice (Table 2).
Effect of second-pass technique on residual tumor and
recurrence
Before comparing the rate of residual tumor in hysterecto-
my specimen, we examined the indication of hysterectomy
in both groups. The indication was mainly positive resection
*Records on parity were available in only 463 women (67.8%).
LEEP, loop electrosurgical excisional procedure.
Clinicopathologic Single-pass Second-pass
p value
characteristics (N=550) (N=133)
Age 0.942
≤36 183 (33.3%) 41 (30.8%)
37-45 183 (33.3%) 50 (37.6%)
46≤ 184 (33.5%) 42 ( 31.6%)
Parity* 0.181
0 27 (7.5%) 12 (11.9%)
1 52 (14.4%) 15 (14.9%)
2≤ 283 (78.2%) 74 (73.3%)
Grade of lesion 0.911
Mild dysplasia 37 (6.7%) 10 (7.5%)
Moderate dysplasia 76 (13.8%) 16 (12.0%)
Severe dysplasia 145 (26.4%) 38 (28.6%)
Carcinoma in situ 292 (53.1%) 69 (51.9%)
Glandular extension 0.866
- 265 (48.2%) 63 (47.4%)
+ 285 (51.8%) 70 (52.6%)
Endocervical margin 0.000
- 398 (72.4%) 116 (87.2%)
+ 152 (27.6%) 17 (12.8%)
Follow-up after LEEP
Immediate hysterectomy 284 (51.6%) 42 (31.6%) 0.000
Adequate follow-up 153 (27.8%) 52 (39.1%)
Inadequate follow-up 113 (20.5%) 39 (29.3%)
Table 1. Clinicopathologic characteristics according to LEEP tech-
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margin or cervical dysplasia (mostly CIS) itself. The portion
of each indication in single-pass group was similar with that
of second-pass group (Table 3).
Rate of residual tumor or recurrence in single-pass group
was similar with that of second-pass group. In women who
underwent immediate hysterectomy, the rate of residual tumor
was not different between two groups (p=0.833). In women
with adequate follow-up, the rate of cytologic or histologic
recurrence was not different between two groups (p=0.828
for cytologic+histologic recurrence; p=0.682 for histologic
recurrence) (Table 4). The rate of treatment failure defined as
residual tumor or histologic recurrence was similar between
two groups (p=0.155, data not shown)
According to univariate and multivariate analysis, the endo-
cervical margin positivity was the only independent risk factor
for treatment failure (OR, 3.40; 95% CI, 2.00-5.80). Glan-
dular extension was associated with treatment failure in uni-
variate analysis (OR, 1.86; 95% CI, 1.11-3.12) but not in
multivariate analysis (OR, 1.35; 95% CI, 0.78-2.33). Age,
parity, grade of lesion, LEEP techniques were not associated
with treatment failure (Table 5).
DISCUSSION
In this study, we showed that the second-pass technique
Risk factors
Univariate analysis, Multivariate analysis,
OR (95% CI) OR (95% CI)
Age
≤36 1.00 (
37-45 0.69 (0.45-1.07) -
46≤ 1.03 (0.68-1.57) -
Parity
0 1.00 (
1 0.49 (0.20-1.24) -
2≤ 0.78 (0.38-1.61) -
Grade of lesion
Mild dysplasia 1.00 ( 1.00 (
Moderate dysplasia 3.79 (0.45-31.74) 3.58 (0.43-30.12)
Severe dysplasia 9.75 (1.30-73.31) 8.15 (1.07-61.99)
Carcinoma in situ 25.58 (3.49-187.64) 17.04 (2.23-129.94)
Glandular extension
- 1.00 ( 1.00 (
+ 3.38 (2.30-4.95) 1.69 (1.06-2.68)
LEEP technique
Single pass 1.00 ( 1.00 (
Second pass 0.38 (0.22-0.66) 0.36 (0.21-0.63)
Table 2. Clinicopathologic risk factors for endocervical margin
positivity
Risk factors
Univariate analysis, Multivariate analysis,
OR (95% CI) OR (95% CI)
Age
≤36 1.00 ( 1.00 (
37-45 1.18 (0.61-2.27) 1.31 (0.67-2.57)
46≤ 1.85 (0.98-3.48) 1.82 (0.95-3.50)
Parity
0 1.00 (
1 4.17 (0.49-35.21) -
2≤ 5.06 (0.67-38.14) -
Grade of lesion
Mild dysplasia 1.00 (
Moderate dysplasia 2.50 (0.28-22.52) -
Severe dysplasia 3.19 (0.40-25.38) -
Carcinoma in situ 6.53 (0.87-49.13) -
Glandular extension
- 1.00 ( 1.00 (
+ 1.86 (1.11-3.12) 1.35 (0.78-2.33)
Endocervical margin
- 1.00 ( 1.00 (
+ 3.86 (2.33-6.40) 3.40 (2.00-5.80)
LEEP technique
Single pass 1.00 ( 1.00 (
Second pass 0.54 (0.26-1.14) 0.62 (0.29-1.32)
Table 5. Clinicopathologic risk factors for treatment failure after
LEEP
Single-pass Second-pass
technique (N=550) technique (N=133)
Immediate hysterectomy 284 (100.0%) 42 (100.0%)
No residual tumor 219 (77.1%) 33 (78.6%)
Residual tumor 65 (22.9%) 9 (21.4%)
Adequate follow-up 153 (100.0%) 52 (100.0%)
No recurrence 137 (89.5%) 46 (88.5%)
Cytologic recurrence* 9 (5.9%) 5 (9.6%)
Histologic recurrence
� 7 (4.6%) 1 (1.9%)
Inadequate follow-up 113 (100.0%) 39 (100.0%)
*, Women with abnormal Pap but negative biopsy result were regarded
as cytologic recurrence; 
� , Women with abnormal Pap and positive biop-
sy result were regarded as histologic recurrence.
LEEP, loop electrosurgical excisional procedure.
Table 4. Residual tumor and recurrence according to LEEP tech-
niques
Indication Single pass Second pass
Positive or close resection margin 125 (44.0%) 20 (47.6%)
Cervical dysplasia 126 (44.4%) 20 (47.6%)
Cervical dysplasia and other disease 12 (4.2%) 1 (2.4%)
Other disease 2 (0.7%) 0 (0.0%)
Patient’s request 2 (0.7%) 0 (0.0%)
Suspicious invasion 1 (0.4%) 1 (2.4%)
Unknown 16 (5.6%) 0 (0.0%)
Sum 284 (100.0%) 42 (100.0%)
LEEP, loop electrosurgical excisional procedure.
LEEP, loop electrosurgical excisional procedure.
Table 3. Indication of immediate hysterectomy according to LEEP
techniques
OR, odds ratio; CI, confidence interval; LEEP, loop electrosurgical exci-
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markedly reduced the endocervical margin positivity after
LEEP. It is well known that the endocervical margin positiv-
ity is a strong indicator of recurrence after LEEP (7). There-
fore, we anticipated that the second-pass technique could also
reduce the treatment failure after LEEP which is defined as
residual tumor or histologic recurrence. However, the second-
pass technique did not reduce the treatment failure. There
could be some explanations. First, the small sample size could
be a problem. Considering that only a small portion of women
actually have residual tumor or recurrence even when the
endocervical margin was positive, the sample size of this study
could be insufficient to reach a statistical significance. Sec-
ond, the selection bias could be a possibility. In the second-
pass group, significantly fewer women underwent hysterec-
tomy than in the single-pass group. It is possible that, by
reducing the endocervical margin positivity, the second-pass
technique excluded low risk women from hysterectomy. As
a result, among the 326 women who underwent the hysterec-
tomy, the second-pass group may contain relatively more
high risk women than the single-pass group. Third, skipped
lesions could have been present. A study about the second-
pass technique also reported that the second-pass did not
reduce the recurrences (7). In addition, the cold knife coniza-
tion resecting nearly twice more tissue than LEEP did not
reduce the residual tumor in hysterectomy specimen (8). These
results could be easily explained by assuming skipped lesions.
We also confirmed that the higher grade lesion and the
glandular extension were indicators of the endocervical mar-
gin positivity. In addition, endocervical margin positivity was
an indicator of treatment failure after LEEP. These findings
were roughly concordant with the previous studies (9-12).
Although the second-pass technique seemed to have some
advantages over single-pass technique, the second-pass tech-
nique also has disadvantages. Because the second-pass resects
more endocervical tissues, it could cause more complications
such as incompetent cervix, cervical stenosis. Therefore, com-
plete topographic evaluation of lesion before LEEP is manda-
tory. In addition, we thought that the second-pass technique
should be cautiously used in women whose childbearing is not
completed.
In conclusion, the second pass technique markedly reduced
the endocervical margin positivity after LEEP, but did not
reduce the residual tumor or recurrences.
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